肝细胞癌分子靶向治疗研究进展
分子靶向药物—激光制导炸弹 主要是针对肿瘤发生、发展过程中的关键大分子,即参与肿瘤发生、发展过程中的细胞信号传导和其他生物学途径的重要靶点,或是通过强力阻止肿瘤血管生成,从而抑制肿瘤细胞的生长、增殖和转移播散,发挥特异性抗肿瘤作用。 * Selection of patients with well preserved liver function (Child–Pugh A) was important to assess the efficacy of the drug inclusion of patients with more advanced liver dysfunction (Child–Pugh B or C) may have masked sorafenib activity due to liver disease-associated deaths. Treatment continued until radiological progression (RECIST) and symptomatic progression, or unacceptable toxicity, or death. Primary endpoints OS measured from date of randomization until date of death fr
原创力文档

文档评论(0)